Evidence map›Paper›PMID 29066189›Full record

ArticleVaccine2017

Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices.

Aaron S Wallace, Fred Willis, Eric Nwaze, Boubacar Dieng, Naawa Sipilanyambe, Danni Daniels, Emmanuel Abanida, Alex Gasasira, Mustapha Mahmud, Tove K Ryman

Registry-linked trialAbstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04658680 (Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality? A Cluster Randomised Trial), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04658680 phase4active not recruitingnot on this mapstarted 2021, after this paper: background citation

Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality? A Cluster Randomised Trial

TypeinterventionalSponsorBandim Health ProjectRan2021 to 2026Enrolled22,800ConditionsInfant Mortality, BCGArmsBCG vaccination at first health facility contact
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Trends in uptake and impact of thermostable vaccines in Africa.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Blockchain Powered Vaccine Efficacy for Pharma Sector.Computational and mathematical methods in medicine · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aaron S WallaceGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: AWallace@cdc.gov.
Fred WillisMaternal and Child Health Team, UNICEF, Abuja, Nigeria.
Eric NwazeImmunization Division, National Primary Health, Abuja, Nigeria.
Boubacar DiengMaternal and Child Health Team, UNICEF, Abuja, Nigeria.
Naawa SipilanyambeMaternal and Child Health Team, UNICEF, Abuja, Nigeria.
Danni DanielsGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Emmanuel AbanidaImmunization Division, National Primary Health, Abuja, Nigeria.
Alex GasasiraVaccines, Immunizations and Biologicals, World Health Organization, Abuja, Nigeria.
Mustapha MahmudImmunization Division, National Primary Health, Abuja, Nigeria.
Tove K RymanBill and Melinda Gates Foundation, Global Immunization Division, Centers for Disease Control and Prevention, Seattle, WA, USA.

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

introductionThe introduction of new vaccines highlights concerns about high vaccine wastage, knowledge of wastage policies and quality of stock management. However, an emphasis on minimizing wastage rates may cause confusion when recommendations are also being made to reduce missed opportunities to routinely vaccinate children. This concern is most relevant for lyophilized vaccines without preservatives [e.g. measles-containing vaccine (MCV)], which can be used for a limited time once reconstituted.

methodsWe sampled 54 health facilities within 11 local government areas (LGAs) in Nigeria and surveyed health sector personnel regarding routine vaccine usage and wastage-related knowledge and practices, conducted facility exit interviews with caregivers of children about missed opportunities for routine vaccination, and abstracted vaccine stock records and vaccination session data over a 6-month period to calculate wastage rates and vaccine vial usage patterns.

resultsNearly half of facilities had incomplete vaccine stock data for calculating wastage rates. Among facilities with sufficient data, mean monthly facility-level wastage rates were between 18 and 35% across all reviewed vaccines, with little difference between lyophilized and liquid vaccines. Most (98%) vaccinators believed high wastage led to recent vaccine stockouts, yet only 55% were familiar with the multi-dose vial policy for minimizing wastage. On average, vaccinators reported that a minimum of six children must be present prior to opening a 10-dose MCV vial. Third dose of diphtheria-tetanus-pertussis vaccine (DTP3) was administered in 84% of sessions and MCV in 63%; however, the number of MCV and DTP3 doses administered were similar indicating the number of children vaccinated with DTP3 and MCV were similar despite less frequent MCV vaccination opportunities. Among caregivers, 30% reported being turned away for vaccination at least once; 53% of these children had not yet received the missed dose. DISCUSSION: Our findings show inadequate implementation of vaccine management guidelines, missed opportunities to vaccinate, and lyophilized vaccine wastage rates below expected rates. Missed opportunities for vaccination may occur due to how the health system's contradicting policies may force health workers to prioritize reduced wastage rates over vaccine administration, particularly for multi-dose vials.

Indexed as

Health Knowledge, Attitudes, PracticeChildDiphtheria-Tetanus-Pertussis VaccineDrug UtilizationHealth PersonnelHealth PolicyHumansImmunization ProgramsInfantMeasles VaccineNigeriaVaccinationVaccinesDiphtheria-Tetanus-Pertussis VaccineMeasles VaccineVaccinesImmunizationMeaslesNigeriaWastage

Identifiers

PMID29066189
PMCPMC5771486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.